Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 90

1.

Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections.

Langereis JD, van der Flier M, de Jonge MI.

Front Immunol. 2018 Aug 23;9:1925. doi: 10.3389/fimmu.2018.01925. eCollection 2018. Review.

2.

Desialylation of Platelets by Pneumococcal Neuraminidase A Induces ADP-Dependent Platelet Hyperreactivity.

Kullaya V, de Jonge MI, Langereis JD, van der Gaast-de Jongh CE, Büll C, Adema GJ, Lefeber D, Cremers AJ, Mmbaga BT, de Groot PG, de Mast Q, van der Ven AJ.

Infect Immun. 2018 Sep 21;86(10). pii: e00213-18. doi: 10.1128/IAI.00213-18. Print 2018 Oct.

PMID:
30037798
3.

Selective Inhibition of Sialic Acid-Based Molecular Mimicry in Haemophilus influenzae Abrogates Serum Resistance.

Heise T, Langereis JD, Rossing E, de Jonge MI, Adema GJ, Büll C, Boltje TJ.

Cell Chem Biol. 2018 Jun 9. pii: S2451-9456(18)30189-2. doi: 10.1016/j.chembiol.2018.05.018. [Epub ahead of print]

PMID:
29983272
4.

The endotoxin-induced pulmonary inflammatory response is enhanced during the acute phase of influenza infection.

Koch RM, Diavatopoulos DA, Ferwerda G, Pickkers P, de Jonge MI, Kox M.

Intensive Care Med Exp. 2018 Jul 5;6(1):15. doi: 10.1186/s40635-018-0182-5.

5.

Selective counting and sizing of single virus particles using fluorescent aptamer-based nanoparticle tracking analysis.

Szakács Z, Mészáros T, de Jonge MI, Gyurcsányi RE.

Nanoscale. 2018 Aug 7;10(29):13942-13948. doi: 10.1039/c8nr01310a. Epub 2018 May 30.

PMID:
29845157
6.

The Contribution of Genetic Variation of Streptococcus Pneumoniae to the Clinical Manifestation of Invasive Pneumococcal Disease.

Cremers AJH, Mobegi FM, van der Gaast-de Jongh C, van Weert M, van Opzeeland FJ, Vehkala M, Knol MJ, Bootsma HJ, Välimäki N, Croucher NJ, Meis JF, Bentley S, van Hijum SAFT, Corander J, Zomer AL, Ferwerda G, de Jonge MI.

Clin Infect Dis. 2018 May 17. doi: 10.1093/cid/ciy417. [Epub ahead of print]

PMID:
29788414
7.

Adaptation of Bordetella pertussis to the Respiratory Tract.

van Beek LF, de Gouw D, Eleveld MJ, Bootsma HJ, de Jonge MI, Mooi FR, Zomer A, Diavatopoulos DA.

J Infect Dis. 2018 May 25;217(12):1987-1996. doi: 10.1093/infdis/jiy125.

PMID:
29528444
8.

For the greater good: Programmed cell death in bacterial communities.

Peeters SH, de Jonge MI.

Microbiol Res. 2018 Mar;207:161-169. doi: 10.1016/j.micres.2017.11.016. Epub 2017 Dec 1. Review.

9.

Short-term repeated HRV-16 exposure results in an attenuated immune response in vivo in humans.

Koch RM, Kox M, van den Kieboom C, Ferwerda G, Gerretsen J, Ten Bruggencate S, van der Hoeven JG, de Jonge MI, Pickkers P.

PLoS One. 2018 Feb 15;13(2):e0191937. doi: 10.1371/journal.pone.0191937. eCollection 2018.

10.

Display of Recombinant Proteins on Bacterial Outer Membrane Vesicles by Using Protein Ligation.

van den Berg van Saparoea HB, Houben D, de Jonge MI, Jong WSP, Luirink J.

Appl Environ Microbiol. 2018 Apr 2;84(8). pii: e02567-17. doi: 10.1128/AEM.02567-17. Print 2018 Apr 15.

11.

Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement Evasion.

van der Maten E, van den Broek B, de Jonge MI, Rensen KJW, Eleveld MJ, Zomer AL, Cremers AJH, Ferwerda G, de Groot R, Langereis JD, van der Flier M.

Infect Immun. 2018 Mar 22;86(4). pii: e00010-18. doi: 10.1128/IAI.00010-18. Print 2018 Apr.

12.

IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation.

Langereis JD, Henriet SS, Kuipers S, Weemaes CMR, van der Burg M, de Jonge MI, van der Flier M.

J Clin Immunol. 2018 Feb;38(2):185-192. doi: 10.1007/s10875-017-0474-7. Epub 2018 Jan 15.

13.

Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses.

Ederveen THA, Ferwerda G, Ahout IM, Vissers M, de Groot R, Boekhorst J, Timmerman HM, Huynen MA, van Hijum SAFT, de Jonge MI.

Microbiome. 2018 Jan 11;6(1):10. doi: 10.1186/s40168-017-0395-y.

14.

Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo.

Koch RM, Kox M, Thijs EJM, Rahamat-Langendoen JC, van de Veerdonk FL, Gerretsen J, Schloesser J, Diavatopoulos D, Rimmelzwaan GF, Netea MG, van der Hoeven JG, de Jonge MI, Pickkers P.

Front Immunol. 2017 Dec 11;8:1600. doi: 10.3389/fimmu.2017.01600. eCollection 2017.

15.

Siglec-1 inhibits RSV-induced interferon gamma production by adult T cells in contrast to newborn T cells.

Jans J, Unger WWJ, Vissers M, Ahout IML, Schreurs I, Wickenhagen A, de Groot R, de Jonge MI, Ferwerda G.

Eur J Immunol. 2018 Apr;48(4):621-631. doi: 10.1002/eji.201747161. Epub 2018 Jan 18.

16.

Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice.

Fransen F, van Beek AA, Borghuis T, Aidy SE, Hugenholtz F, van der Gaast-de Jongh C, Savelkoul HFJ, De Jonge MI, Boekschoten MV, Smidt H, Faas MM, de Vos P.

Front Immunol. 2017 Nov 2;8:1385. doi: 10.3389/fimmu.2017.01385. eCollection 2017.

17.

Spleen-derived IFN-γ induces generation of PD-L1+-suppressive neutrophils during endotoxemia.

Langereis JD, Pickkers P, de Kleijn S, Gerretsen J, de Jonge MI, Kox M.

J Leukoc Biol. 2017 Dec;102(6):1401-1409. doi: 10.1189/jlb.3A0217-051RR. Epub 2017 Oct 3.

PMID:
28974543
18.

Genetic background impacts vaccine-induced reduction of pneumococcal colonization.

Kuipers K, van Selm S, van Opzeeland F, Langereis JD, Verhagen LM, Diavatopoulos DA, de Jonge MI.

Vaccine. 2017 Sep 18;35(39):5235-5241. doi: 10.1016/j.vaccine.2017.08.023. Epub 2017 Aug 17.

19.

Platelets Modulate Innate Immune Response Against Human Respiratory Syncytial Virus In Vitro.

Kullaya VI, de Mast Q, van der Ven A, elMoussaoui H, Kibiki G, Simonetti E, de Jonge MI, Ferwerda G.

Viral Immunol. 2017 Oct;30(8):576-581. doi: 10.1089/vim.2016.0161. Epub 2017 Aug 7.

PMID:
28783457
20.

Th17-Mediated Cross Protection against Pneumococcal Carriage by Vaccination with a Variable Antigen.

Kuipers K, Jong WSP, van der Gaast-de Jongh CE, Houben D, van Opzeeland F, Simonetti E, van Selm S, de Groot R, Koenders MI, Azarian T, Pupo E, van der Ley P, Langereis JD, Zomer A, Luirink J, de Jonge MI.

Infect Immun. 2017 Sep 20;85(10). pii: e00281-17. doi: 10.1128/IAI.00281-17. Print 2017 Oct.

Supplemental Content

Loading ...
Support Center